This video is intended for U.S. HCPs only.
Ken Keller, Global Head of the Daiichi Sankyo #Oncology Business, explores our goals with DXd ADC Technology.
We’re on a journey that seeks to go beyond making incremental differences. By striving to create new standards of care for people with #cancer around the world, we honor our commitments to all those who depend on us to provide innovative therapies to patients.
Learn about our proprietary DXd ADC Technology: https://bit.ly/3qKHi5w
Source Daiichi Sankyo US YouTube
